Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Johnson and Johnson
Cipla
Chubb
Federal Trade Commission
Healthtrust
McKesson
AstraZeneca
Deloitte

Generated: December 14, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR DEFINITY

« Back to Dashboard

Clinical Trials for Definity

Trial ID Title Status Sponsor Phase Summary
NCT00162058 A Phase II Study of DMP 115 to Assess Focal Liver Lesions Completed Lantheus Medical Imaging Phase 2 To determine the optimal dose of DMP 115 to image liver lesions and to assess whether contrast can improve the detection of focal liver lesions.
NCT00162370 A Study of Stress Echocardiography in Post-Menopausal Women at Risk for Coronary Disease Completed Lantheus Medical Imaging Phase 4 The study is designed to see if stress echocardiography can be used as a screening exam in peri-, or post-menopausal women with a risk of developing of coronary artery disease and experiencing future cardiac events.
NCT00239525 3-D Transcranial Ultrasound Analysis Study Completed Duke University N/A The purpose of this study is to investigate real time 3-D ultrasound imaging of the brain for the diagnosis and evaluation of stroke.
NCT00401687 DMP115 in Patients With an Ejection Fraction Between 25%-40% to Evaluate the Use of Contrast Echocardiography to Assess Heart Function Completed Lantheus Medical Imaging Phase 4 The purpose of this clinical research study is to demonstrate the ability of Definity® enhanced versus unenhanced cardiac ultrasound to improve the accuracy and reproducibility of left ventricular ejection fraction (EF) when compared to magnetic resonance imaging (MRI).
NCT00507806 Microbubble-Enhanced Clotbust Treatment of Acute Ischemic Stroke Terminated ImaRx Therapeutics Phase 1/Phase 2 The study is designed to examine the safety, tolerability, and activity of a combination of microbubbles (perflutren lipid microsphere [Definity®]) and continuous monitoring with 2 MHz transcranial Doppler ultrasound (TCD) as an adjunctive therapy to tissue plasminogen activator (tPA) treatment in subjects with acute ischemic stroke.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Definity

Condition Name

Condition Name for Definity
Intervention Trials
Breast Cancer 3
Coronary Artery Disease 3
Cardiac Disease 2
Hepatocellular Carcinoma 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Definity
Intervention Trials
Heart Diseases 4
Coronary Disease 3
Carcinoma, Renal Cell 3
Coronary Artery Disease 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Definity

Trials by Country

Trials by Country for Definity
Location Trials
United States 63
Canada 2
United Kingdom 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Definity
Location Trials
Pennsylvania 7
Minnesota 7
Texas 6
North Carolina 6
California 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Definity

Clinical Trial Phase

Clinical Trial Phase for Definity
Clinical Trial Phase Trials
Phase 4 9
Phase 3 3
Phase 2 7
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Definity
Clinical Trial Phase Trials
Completed 14
Not yet recruiting 8
Recruiting 7
[disabled in preview] 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Definity

Sponsor Name

Sponsor Name for Definity
Sponsor Trials
Lantheus Medical Imaging 15
University of Virginia 4
National Institutes of Health (NIH) 3
[disabled in preview] 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Definity
Sponsor Trials
Other 49
Industry 21
NIH 7
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Express Scripts
Farmers Insurance
Fuji
Teva
Chubb
Accenture
Dow
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.